Mercy South — St Louis, Missouri

Mercy South is a clinical research site located in St Louis, Missouri, United States 63128.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Mercy South has participated in 6 clinical trials with 5 currently active.

Therapeutic areas: Peripheral Arterial Disease, Critical Limb Ischemia, Advanced Non-Small Cell Lung Cancer.

Sponsors: ReFlow Medical, Inc., Regeneron Pharmaceuticals, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mercy South?

Mercy South has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mercy South conducted?

Mercy South has 6 clinical trials on record, with 5 currently active. Their work covers Peripheral Arterial Disease, Critical Limb Ischemia, Advanced Non-Small Cell Lung Cancer.

Is Mercy South accredited by Crixeo Health?

Mercy South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mercy South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.